This inventor holds 1 USPTO granted patent. Top assignee: Universitéde Montreal. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of Jean-Gilles Latour
Introduction
Jean-Gilles Latour is a notable inventor based in Saint-Eustache, Canada. He has made significant contributions to the field of myocardial protection during ischemia and reperfusion. His innovative approach involves the use of benzothiazepine derivatives to enhance patient outcomes.
Latest Patents
Latour holds a patent for his invention titled "Myocardial protection during ischemia and reperfusion." This patent describes a method of administering an effective amount of a benzothiazepine derivative to achieve myocardial protection. The chemical formula for these derivatives is specified in the patent documentation.
Career Highlights
Latour is affiliated with the Université de Montréal, where he has been involved in research and development in the medical field. His work focuses on improving patient care through innovative solutions in cardiology.
Collaborations
He has collaborated with notable colleagues, including Denis Gravel and Serge Benoît, contributing to advancements in their shared field of expertise.
Conclusion
Jean-Gilles Latour's work exemplifies the impact of innovation in medicine, particularly in the area of myocardial protection. His contributions continue to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile